•  

    CHEMO

    We conduct research, development and production of active pharmaceutical ingredients and finished drug forms.

     

  •  

    CHEMO

    We conduct research, development and production of active pharmaceutical ingredients and finished drug forms.

     

  •  

    CHEMO

    We conduct research, development and production of active pharmaceutical ingredients and finished drug forms.

     

  •  

    CHEMO

    We conduct research, development and production of active pharmaceutical ingredients and finished drug forms.

     

A world leading company

Chemo reaches the entire value chain of the pharmaceutical industry, from development and registration to quality control, manufacturing and direct distribution to clients.

Chemo has a presence in more than 40 countries and has more than 11 manufacturing sites, 9 R&D centers and more than 5,000 professionals. All its plants and products meet international Good Manufacturing Practices (GMP), in compliance with US Food and Drug Administration (FDA) and European Medicines Agency (EMA) requirements.

In Argentina, Chemo is part of a public-private consortium focused on research, development and production of innovative medicines. This public-private cooperation consortium network has more than 100 highly skilled professionals, and includes renowned institutions, such as the National Scientific and Technical Research Center (CONICET), University of Buenos Aires, the Ángel Roffo Oncology Institute, and University of Quilmes, among others.

+ Read more

News Chemo

(Español) 31 de agosto de 2017

Estados Unidos aprueba el benznidazol para el tratamiento de niños con la enfermedad de Chagas

Washington D.C./Buenos Aires/Madrid/Ginebra – 31 de agosto de 2017 La Fundación Mundo Sano, Grupo Insud y Laboratorios Elea tienen el orgullo de comunicar que, el 29 de agosto, la Administración de Alimentos y Fármacos de los Estados Unidos (FDA, por … Continue reading

+
(Español) 13-5-2017 Agencia EFE

Spain receives an investment of US $ 17 million

Argentine multinational Chemo, of Grupo Insud, invested almost 17.5 million dollars in Spain in a new plant of injectable medicines that has just inaugurated, informed Efe sources of the Insud Group. Under the name Universal Farma, the new plant has … Continue reading

+